Strs Ohio Grows Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Strs Ohio increased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 3.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 40,400 shares of the company’s stock after buying an additional 1,400 shares during the quarter. Strs Ohio’s holdings in Option Care Health were worth $1,361,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. First Horizon Advisors Inc. purchased a new position in shares of Option Care Health during the third quarter worth about $37,000. Headlands Technologies LLC grew its holdings in shares of Option Care Health by 5,796.7% during the third quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock worth $57,000 after buying an additional 1,739 shares during the last quarter. IFP Advisors Inc grew its holdings in shares of Option Care Health by 20,350.0% during the third quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock worth $79,000 after buying an additional 2,442 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Option Care Health by 219.6% during the third quarter. Fifth Third Bancorp now owns 2,723 shares of the company’s stock worth $88,000 after buying an additional 1,871 shares during the last quarter. Finally, International Assets Investment Management LLC boosted its holdings in Option Care Health by 1,513.7% in the 4th quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock valued at $103,000 after purchasing an additional 2,876 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of OPCH opened at $30.41 on Tuesday. The stock’s 50 day moving average is $32.22 and its two-hundred day moving average is $31.54. Option Care Health, Inc. has a twelve month low of $24.23 and a twelve month high of $35.74. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $5.29 billion, a PE ratio of 20.69, a P/E/G ratio of 1.77 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Thursday, February 22nd. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The company had revenue of $1.12 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period last year, the firm earned $0.26 EPS. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Research analysts anticipate that Option Care Health, Inc. will post 1.13 earnings per share for the current year.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of Option Care Health stock in a transaction dated Monday, February 26th. The stock was bought at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the transaction, the director now owns 269,528 shares in the company, valued at $8,503,608.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on OPCH. Barrington Research lifted their price objective on Option Care Health from $35.00 to $38.00 and gave the company an “outperform” rating in a report on Friday, February 23rd. Jefferies Financial Group lifted their price objective on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a report on Monday, March 4th.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.